Sanofi: Annual General Meeting of April 30, 2019
30 Avril 2019 - 6:01PM
|
Press
Release Source: Sanofi (EURONEXT: SAN) (NASDAQ: SNY)
|
Annual General Meeting of April 30, 2019
- Approval of the financial
statements for the fiscal year 2018
- Dividend of €3.07 per share
payable as of May 13, 2019
- Board composition :
renewals and ratification of a co-opting director
Paris, France - April 30, 2019 - The
Combined General Shareholders' Meeting of Sanofi was held on April
30, 2019 at the Palais des Congrès in Paris, under the chairmanship
of Serge Weinberg. All resolutions submitted to the vote were
adopted by the shareholders.
The General Meeting approved, among other
resolutions, the individual Company and consolidated financial
statements for the fiscal year 2018. The General Meeting decided
the distribution of a cash dividend in the amount of € 3.07 per
share with payment as of May 13, 2019.
The General Meeting also renewed as Directors
Suet-Fern Lee and Serge Weinberg and ratified the co-opting of
Christophe Babule.
Following the General Meeting, the Board of
Directors is still comprised of 16 members, of whom six are women
and two are Directors representing employees. The Board of
Directors remains for a large majority comprised of independent
Directors.
The voting results and the audiocast of the
Annual General Meeting are available on:
www.sanofi.com/AG2019
During the Board of Directors session following
the meeting, Serge Weinberg was renewed as Chairman of the Board,
Melanie Lee was appointed as member of the appointment, governance
and CSR Committee and Carole Piwnica was appointed as member of the
compensation Committee.
About Sanofi Sanofi is dedicated to supporting
people through their health challenges. We are a global
biopharmaceutical company focused on human health. We prevent
illness with vaccines, provide innovative treatments to fight pain
and ease suffering. We stand by the few who suffer from rare
diseases and the millions with long-term chronic conditions.
With more than 100,000 people in 100 countries, Sanofi is
transforming scientific innovation into healthcare solutions around
the globe. Sanofi, Empowering Life |
Media Relations Contact Quentin Vivant Tel.: +33 (0)1 53 77
46 46 mr@sanofi.com |
Investor Relations
Contact George Grofik Tel.: +33 (0)1 53 77 45 45
ir@sanofi.com |
|
About Sanofi
Sanofi is dedicated to supporting people through
their health challenges. We are a global biopharmaceutical company
focused on human health. We prevent illness with vaccines, provide
innovative treatments to fight pain and ease suffering. We stand by
the few who suffer from rare
Sanofi (EU:SAN)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Sanofi (EU:SAN)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024